Miltenyi Biomedicine
Miltenyi Biomedicine is a Germany-based cell therapy company running 5 late-stage cancer trials of zamtocabtagene autoleucel (MB-CART2019.1) and MB-CART2019.1 in diffuse large B-cell lymphoma, acute myeloid leukaemia and primary CNS lymphoma.
Overview
Miltenyi Biomedicine, based in Bergisch Gladbach, Germany, is a cell therapy company and part of Miltenyi Biotec (Miltenyi group). Develops personalised cell and gene therapies, specifically CAR-T cell therapies for oncology and autoimmune diseases; part of the Miltenyi group alongside Miltenyi Biotec. On ClinicalTrials.gov it is the lead sponsor of 5 recruiting or active phase 2 and phase 3 interventional cancer trials, testing zamtocabtagene autoleucel (MB-CART2019.1) and MB-CART2019.1 in diffuse large B-cell lymphoma, acute myeloid leukaemia, primary CNS lymphoma and mantle cell lymphoma. The largest, NCT04792489 (DALY II USA/ MB-CART2019.1 for DLBCL), plans to enrol 315 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Scorecard
All companies- phase 1/2 +1
- targets +4
- modalities +2
Similar pages
not linked directly; found by shared links- CompanyCuris
Shares Primary CNS lymphoma and the tag ctgov-sponsor.
- CompanyRanok Therapeutics (Hangzhou)
Shares Diffuse large B-cell lymphoma and the tag ctgov-sponsor.
- CompanyOrca Biosystems
Shares Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyTreadwell Therapeutics
Shares Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyOncoVerity
Shares Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyMolecular Partners
Shares Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyRyvu Therapeutics
Shares Acute myeloid leukaemia and the tag ctgov-sponsor.
- CompanyKartos Therapeutics
Shares Diffuse large B-cell lymphoma and the tag ctgov-sponsor.